Acrivon Therapeutics, Inc.
ACRV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781174
In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Acrivon Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +1 vs. Q1 2023
- Shares held
- 15.1M
- −89.7K (−0.6%) vs. Q1 2023
- Total value
- $196.0M
- +$4.98M (+2.6%) vs. Q1 2023
- New holders
- 5
- 17 more added
- Sold out
- 4
- 11 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $38.1M |
| Q1 2026 | 44 | $22.6M |
| Q4 2025 | 48 | $44.9M |
| Q3 2025 | 48 | $31.7M |
| Q2 2025 | 53 | $21.2M |
| Q1 2025 | 63 | $45.7M |
| Q4 2024 | 63 | $140.0M |
| Q3 2024 | 55 | $160.8M |
| Q2 2024 | 55 | $136.1M |
| Q1 2024 | 48 | $109.0M |
| Q4 2023 | 42 | $74.5M |
| Q3 2023 | 43 | $144.3M |
| Q2 2023 | 40 | $196.0M |
| Q1 2023 | 39 | $191.1M |
| Q4 2022 | 18 | $170.4M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Acrivon Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 4,810,508 | $62.3M | 1.18% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 3,007,858 | $39.0M | 1.13% | 00.0% | Unchanged |
| Sands Capital Ventures, LLC | 1,652,605 | $21.4M | 6.34% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,649,646 | $21.4M | 0.02% | +8,624+0.5% | Added |
| Wellington Management Group LLP | 888,130 | $11.5M | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 597,469 | $7.74M | 0.02% | 00.0% | Unchanged |
| BlackRock Inc. | 533,355 | $6.91M | 0.00% | +59,128+12.5% | Added |
| NEA Management Company, LLC | 481,677 | $6.24M | 0.48% | 00.0% | Unchanged |
| Vanguard Group Inc | 403,275 | $5.23M | 0.00% | −5,940−1.5% | Reduced |
| Federated Hermes, Inc. | 304,411 | $3.95M | 0.01% | −309,214−50.4% | Reduced |
| Geode Capital Management, LLC | 178,453 | $2.31M | 0.00% | +3,049+1.7% | Added |
| State Street Corp | 125,976 | $1.63M | 0.00% | +40,637+47.6% | Added |
| UBS Oconnor LLC | 100,000 | $1.30M | 0.03% | +100,000 | New |
| DAFNA Capital Management LLC | 76,852 | $996.0K | 0.27% | +25,704+50.3% | Added |
| Northern Trust Corp | 68,678 | $890.1K | 0.00% | −1,073−1.5% | Reduced |
| Charles Schwab Investment Management Inc | 60,958 | $790.0K | 0.00% | +2,749+4.7% | Added |
| D. E. Shaw & Co., Inc. | 46,910 | $608.0K | 0.00% | −14,986−24.2% | Reduced |
| Bank of New York Mellon Corp | 24,795 | $321.3K | 0.00% | +1,958+8.6% | Added |
| Barclays PLC | 14,263 | $184.8K | 0.00% | −2,720−16.0% | Reduced |
| Nuveen Asset Management, LLC | 11,821 | $153.2K | 0.00% | +11,821 | New |
| Exchange Traded Concepts, LLC | 11,709 | $151.7K | 0.00% | +11,709 | New |
| AAFCPAs Wealth Management, LLC | 10,678 | $138.4K | 0.09% | +10,678 | New |
| UBS Group AG | 9,780 | $126.7K | 0.00% | +4,384+81.2% | Added |
| Rhumbline Advisers | 8,986 | $116.5K | 0.00% | +8,986 | New |
| Morgan Stanley | 8,505 | $110.2K | 0.00% | +2,881+51.2% | Added |
| Bank of America Corp | 7,624 | $98.8K | 0.00% | +1,768+30.2% | Added |
| JPMorgan Chase & Co | 6,927 | $89.8K | 0.00% | +297+4.5% | Added |
| American International Group, Inc. | 4,183 | $54.2K | 0.00% | +5+0.1% | Added |
| Deutsche Bank AG | 4,062 | $52.6K | 0.00% | −1,307−24.3% | Reduced |
| Wells Fargo & Company | 3,305 | $42.8K | 0.00% | +1,717+108.1% | Added |
| California State Teachers Retirement System | 2,891 | $37.5K | 0.00% | −327−10.2% | Reduced |
| Citigroup Inc | 2,790 | $36.2K | 0.00% | +2,588+1,281.2% | Added |
| New York State Common Retirement Fund | 2,275 | $29.5K | 0.00% | +69+3.1% | Added |
| Royal Bank of Canada | 907 | $12.0K | 0.00% | +242+36.4% | Added |
| Legal & General Group Plc | 839 | $10.9K | 0.00% | −85−9.2% | Reduced |
| STRS Ohio | 800 | $10.0K | 0.00% | −1,000−55.6% | Reduced |
| Amalgamated Bank | 781 | $10.0K | 0.00% | −349−30.9% | Reduced |
| Tower Research Capital LLC (TRC) | 732 | $9.49K | 0.00% | −360−33.0% | Reduced |
| Ameritas Investment Partners, Inc. | 695 | $9.01K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 422 | $5.47K | 0.00% | +300+245.9% | Added |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −32,262−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −13,718−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −5,081−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −523−100.0% | Sold out |